Common Stock and Common Stock Equivalents (Narrative) (Details) - USD ($)	12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Dec. 10, 2020	Dec. 03, 2018
Common Stock And Common Stock Equivalents [Line Items]
Share authorised and reseved for issuance	194,451		200,000	120,000
Stock-based compensation expense	$ 3,369	$ 1,637
Unrecognized stock-based compensation cost	$ 0
Years over which unrecognized stock-based compensation expense is expected to be recognized	2 years
Aggregate intrinsic value of options outstanding	$ 0	$ 0
Director [Member]
Common Stock And Common Stock Equivalents [Line Items]
Restricted common share granted	20,000	20,000
Employee [Member]
Common Stock And Common Stock Equivalents [Line Items]
Restricted common share granted	11,633	11,633